Previous 10 | Next 10 |
2024-01-19 20:21:00 ET Summary The Akre Focus Fund invests in a small number of what we believe to be extraordinary businesses that are run by talented and honest managers who wisely reinvest free cash flow. The Akre Focus Fund’s fourth quarter 2023 performance for the Inst...
2024-01-19 08:00:00 ET Summary The healthcare sector is overvalued by 12.5% based on 11-year averages. Nevertheless, the healthcare providers industry shows a good value score. iShares U.S. Healthcare ETF is an unattractive alternative to XLV. We look at 10 healthcare stocks c...
2024-01-18 12:54:30 ET More on Danaher Danaher Corporation (DHR) 42nd Annual JPMorgan Healthcare Conference (Transcript) Danaher: Continuously Compounding My Top 2024 Stock Pick: Danaher Danaher gives Q4 guidance, expects low double-digit drop in revenue ...
2024-01-18 08:45:00 ET Summary Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. The Headwaters Capital Management, LLC (“Headwaters Capital,” “Headwaters,” or the ...
Vancouver, British Columbia--(Newsfile Corp. - January 17, 2024) - Discovery Harbour Resources Corp. (TSXV: DHR) (OTC Pink: DCHRF) (FSE: 4GW) (the " Company " or " Discovery Harbour ") is pleased to announce a non-brokered private placement consisting of the issuance of up to 4,700,000 units (e...
2024-01-16 11:00:00 ET Summary IDEXX Laboratories has outperformed the broader market and continues to show strong growth in its diagnostic products and services for pets. The company is shifting towards recurring revenue streams, which improves sales visibility and customer reten...
2024-01-12 11:27:00 ET Summary Horiba is likely undervalued due to it being under followed, and offers a rare combination of a quality business at an attractive price. The company has high market share in specialized devices in various industries, including automotive, process &am...
2024-01-11 20:25:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
2024-01-11 17:43:47 ET Summary VLTO is down by mid-single digits since it made its debut on the bourses. We like the reliability of the topline and the strong FCF generation. VLTO carries ample debt, and given its predilection towards strategic M&A, dividend growth prospec...
2024-01-10 13:00:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...